SKYE   $0.0156  -2.50% Market Closed

Skye Bioscience Inc
Total Cash 1.38M
totalCashPerShare 0.049
EBITDA -13.40M
Total Debt 4.62M
quickRatio 0.141
currentRatio 0.838
Total Revenue
debtToEquity
Revenue/Share
ROA -0.80279
ROE
grossProfits
freeCashflow -10.91M
operatingCashflow -13.95M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 405.66M
forwardPE -17.0
floatShares 14.99M
sharesOutstanding 28.06M
sharesShort
sharesShortPriorMonth
dateShortInterest
sharesPercentSharesOut
heldPercentInsiders 0.08%
heldPercentInstitutions 0.55%
Short Ratio help_outline
shortPercentOfFloat
impliedSharesOutstanding
bookValue -0.173
Price To Book help_outline
earningsQuarterlyGrowth
netIncomeToCommon -37.64M
trailingEps -5.37%
forwardEps -0.92%
enterpriseToEbitda -30.28
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.16 1Q 2024
institutionsCount 5
lastUpdated April 1, 2024, 2:57 p.m.